The Centers for Disease Control and Prevention yesterday recommended clinicians test all sexually active patients with monkeypox symptoms for HIV and other sexually transmitted infections due to the risk for severe monkeypox in individuals with HIV and other immunocompromising conditions. Among other actions, the agency recommends clinicians consider early treatment with the antiviral drug tecovirimat for immunocompromised patients diagnosed with monkeypox.

Related News Articles

Headline
The World Health Organization today recommended a new name for monkeypox that is intended to mitigate a rise in related racist and stigmatizing language…
Headline
The Department of Health and Human Services today renewed the nation’s monkeypox public health emergency declaration for another 90 days. When the PHE was…
Headline
As the monkeypox outbreak slows in the U.S., a new report from the Centers for Disease Control and Prevention highlights devastating outcomes of monkeypox for…
Headline
The Centers for Disease Control and Prevention today reported the first U.S. monkeypox case in a health care worker since the outbreak began in May. The report…
Headline
The Food and Drug Administration Friday authorized for emergency use the first commercial test kit to detect monkeypox in lesion swab specimens. Only…
Headline
Health and Human Services Secretary Xavier Becerra last week extended for 10 years his Aug. 4 public health emergency for monkeypox under the Public Readiness…